FDA.reportPublic FDA data

Application 201836

Type
ANDA
Sponsor
SAGENT PHARMS INC

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001CISATRACURIUM BESYLATECISATRACURIUM BESYLATEINJECTABLE;INJECTIONEQ 2MG BASE/MLNoNo
002CISATRACURIUM BESYLATECISATRACURIUM BESYLATEINJECTABLE;INJECTIONEQ 10MG BASE/MLNoNo

NDC Listings For This Application#

NDC, Name, Nonproprietary name table
NDCNameNonproprietary nameLabelerMarketing categoryStatus
25021-668Cisatracurium Besylatecisatracurium besylateSagent PharmaceuticalsANDACurrent
25021-668Cisatracurium Besylatecisatracurium besylateSagent PharmaceuticalsANDACurrent
25021-669Cisatracurium Besylatecisatracurium besylateSagent PharmaceuticalsANDACurrent
25021-669Cisatracurium Besylatecisatracurium besylateSagent PharmaceuticalsANDACurrent